Frontiers in Pharmacology | Cardiovascular and Smooth Muscle Pharmacology

Brief Research Report

Published on 18 Feb 2025

Ivabradine in treatment of symptomatic heart failure and supraventricular tachycardias in patients under six months of age

in Cardiovascular and Smooth Muscle Pharmacology

L. Gómez-Ganda
C. J. Parramón-Teixidó
G. Giralt-García
C. Fernández-García
Q. Ferrer-Menduiña
M. J. Cabañas-Poy

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1502375

157 views

Review

Published on 18 Feb 2025

A review of recent advances in anesthetic drugs for patients undergoing cardiac surgery

in Cardiovascular and Smooth Muscle Pharmacology

Yutian Sun
Xiangyou Sun
Haibo Wu
Zhaoyang Xiao
Wei Luo

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1533162

217 views

Original Research

Accepted on 17 Feb 2025

Metabolomics of the effects of Yishenjiangya granules in older adults with hypertension

in Cardiovascular and Smooth Muscle Pharmacology

Yongbo Ma
Yingying Liu
Li Zhuang
Xia Dai
Li Yao
Jie Yu
Lei Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1491935

Original Research

Published on 17 Feb 2025

Comparison of the effects of perioperative fentanyl and morphine use on the short-term prognosis of patients with cardiac surgery in the ICU

in Cardiovascular and Smooth Muscle Pharmacology

Jingtao Zhong
Runqian Sui
Jie Zi
Anbiao Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1453835

192 views

Review

Published on 14 Feb 2025

Current usage of inclisiran for cardiovascular diseases: overview of current clinical trials

in Cardiovascular and Smooth Muscle Pharmacology

Maan H. Harbi

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1449712

274 views

Original Research

Published on 14 Feb 2025

Cinnamic acid alleviates hypertensive left ventricular hypertrophy by antagonizing the vasopressor activity and the pro-cardiac hypertrophic signaling of angiotensin II

in Cardiovascular and Smooth Muscle Pharmacology

Yimeng Cui
Yawei Yang
Xinmiao Tang
Peiwei Wang
Jingang Cui
Yu Chen
Teng Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1555991

191 views

Editorial

Published on 14 Feb 2025

Editorial: Reviews in cardiovascular pharmacology: 2023

in Cardiovascular and Smooth Muscle Pharmacology

Yusof Kamisah
Ismail Laher
Mas Rizky A. A. Syamsunarno

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1566159

154 views

Review

Accepted on 12 Feb 2025

Potential Therapeutic Mechanisms of Draconis Resina in Cardiovascular Diseases-A Narrative Review

in Cardiovascular and Smooth Muscle Pharmacology

WANG JING
XiuSong Tang
Peng Lan
Bin Liang
Yu Fang
HongBo Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1531873

Review

Published on 12 Feb 2025

MicroRNAs in atrial fibrillation – have we discovered the Holy Grail or opened a Pandora’s box?

in Cardiovascular and Smooth Muscle Pharmacology

Alkora Ioana Balan
Alina Scridon

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1535621

209 views

Review

Accepted on 10 Feb 2025

Targeting miRNA with Flavonoids: Unlocking Novel Pathways in Cardiovascular Disease Management

in Cardiovascular and Smooth Muscle Pharmacology

Rony Abdi Syahputra
Arya Tjipta Prananda
Princella Halim

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1532986

Review

Accepted on 10 Feb 2025

Effects of Chinese Medicine on Modulating Interleukin-17regulated Macrophages in Coronary Heart Disease

in Cardiovascular and Smooth Muscle Pharmacology

Qing Liu
Peizhong Liu
Qingqing Liu
Chuangpeng Li
Zhen Zhao
Dawei Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1499786

Original Research

Accepted on 10 Feb 2025

In silico predictions of drug-induced changes in human cardiac contractility agree with experimental recordings

in Cardiovascular and Smooth Muscle Pharmacology

Cristian Trovato
Stefano Longobardi
Elisa Passini
Kylie A. Beattie
Maxx Holmes
Khuram Chaudhary
Eric Rossman
Blanca Rodriguez

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1500668

Review

Accepted on 10 Feb 2025

Effect of Sodium-Glucose Co-Transporter 2 Inhibitors on Coronary Microcirculation

in Cardiovascular and Smooth Muscle Pharmacology

Shaoxin Chen
Weiqian Ou
Shuguang Gan
Lixian Chen
Baohua Liu
Zhenhong Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1523727

Original Research

Accepted on 10 Feb 2025

Development and validation of a prediction model for VTE risk in gastric and esophageal cancer patients

in Cardiovascular and Smooth Muscle Pharmacology

Xingyue Zheng
Liuyun Wu
Lian Li
Yin Wang
Qinan Yin
Lizhu Han
Xingwei Wu
Bian Yuan

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1448879

Editorial

Published on 10 Feb 2025

Editorial: Exploring small molecule inhibitors in cardiovascular and cerebrovascular diseases

in Cardiovascular and Smooth Muscle Pharmacology

Basveshwar Gawali
Shweta Shrivastava
R. Uday Kumar
Satyendra Kumar Rajput
Manish Kumar Jeengar

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1559488

297 views

Review

Accepted on 06 Feb 2025

Acacetin as a Natural Cardiovascular Therapeutic: Mechanisms and Preclinical Evidence

in Cardiovascular and Smooth Muscle Pharmacology

Zihe Zhou
Tao Li
Helin Qin
Xinyu Wang
Shanshan He
Zhongcai Fan
Qiang Ye
Yanfei Du

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1493981

Navigation group

Articles

Ivabradine in treatment of symptomatic heart failure and supraventricular tachycardias in patients under six months of age

A review of recent advances in anesthetic drugs for patients undergoing cardiac surgery

Metabolomics of the effects of Yishenjiangya granules in older adults with hypertension

Comparison of the effects of perioperative fentanyl and morphine use on the short-term prognosis of patients with cardiac surgery in the ICU

Current usage of inclisiran for cardiovascular diseases: overview of current clinical trials

Cinnamic acid alleviates hypertensive left ventricular hypertrophy by antagonizing the vasopressor activity and the pro-cardiac hypertrophic signaling of angiotensin II

Editorial: Reviews in cardiovascular pharmacology: 2023

Potential Therapeutic Mechanisms of Draconis Resina in Cardiovascular Diseases-A Narrative Review

MicroRNAs in atrial fibrillation – have we discovered the Holy Grail or opened a Pandora’s box?

Targeting miRNA with Flavonoids: Unlocking Novel Pathways in Cardiovascular Disease Management

Effects of Chinese Medicine on Modulating Interleukin-17regulated Macrophages in Coronary Heart Disease

In silico predictions of drug-induced changes in human cardiac contractility agree with experimental recordings

Effect of Sodium-Glucose Co-Transporter 2 Inhibitors on Coronary Microcirculation

Development and validation of a prediction model for VTE risk in gastric and esophageal cancer patients

Editorial: Exploring small molecule inhibitors in cardiovascular and cerebrovascular diseases

Acacetin as a Natural Cardiovascular Therapeutic: Mechanisms and Preclinical Evidence